Re: BETonMACE top line data
in response to
by
posted on
Jan 16, 2018 07:08PM
Tada -
Thanks for the great post!
Was there an issue in the Assure trial when patients stopped therapy? As I recall the dosing period was far less than two years - this is new territory.
chicagoest